Schechter Adam H 4
4 · LABCORP HOLDINGS INC. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Labcorp (LH) CEO Adam Schechter Receives 7,709 Shares via RSU Vesting
What Happened Adam H. Schechter, President & CEO (and Director) of Labcorp Holdings (LH), had Restricted Stock Units (RSUs) convert to common stock in early February 2026. He acquired a total of 7,709 shares through conversion/vesting (4,460 on Feb 6 and 3,249 on Feb 7). To satisfy tax withholding obligations, 2,667 shares were surrendered (stock withheld) on Feb 6 and Feb 9 — 1,315 shares at $277.20 ($364,518) and 1,352 shares at $274.01 ($370,462), totaling $734,980 withheld. Net effect: Schechter retained about 5,042 additional shares after withholding. The conversions show $0.00 exercise price (typical for RSU settlement).
Key Details
- Transaction dates: Feb 6, 2026 (4,460 RSU conversions; 1,315 shares withheld at $277.20) and Feb 7, 2026 (3,249 RSU conversions; 1,352 shares withheld on Feb 9 at $274.01).
- Withheld value: $364,518 + $370,462 = $734,980 (approx. $735K) paid via share withholding to cover taxes.
- Net shares added: 7,709 acquired − 2,667 withheld = +5,042 net shares.
- Footnotes: F1 = each RSU converts to one share; F2 = stock withholding for taxes; F3/F5 = vesting schedule details for the underlying grants; F4 = reflects aggregate RSUs held (aggregate number not specified here).
- Filing: Form 4 filed Feb 10, 2026 covering Feb 6–9 transactions (no late filing indicated).
- Remark: Exhibit 24 (Power of Attorney) included.
Context These transactions reflect RSU vesting and routine tax-withholding via share surrender (a common, non‑market-sale method of meeting tax obligations). The RSU conversions had no exercise price (not an options purchase); withheld shares were used for taxes rather than sold on the open market. Such vesting increases insider ownership but withholding is administrative and not a directional market signal.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-06+4,460→ 92,034 total - Tax Payment
Common Stock
[F2]2026-02-06$277.20/sh−1,315$364,518→ 90,719 total - Exercise/Conversion
Common Stock
[F1]2026-02-07+3,249→ 93,968 total - Tax Payment
Common Stock
[F2]2026-02-09$274.01/sh−1,352$370,462→ 92,616 total - Exercise/Conversion
Restricted Stock Unit
[F1][F3][F4]2026-02-06−4,460→ 18,679 total→ Common Stock (4,460 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F5][F4]2026-02-07−3,249→ 15,430 total→ Common Stock (3,249 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
- [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F5]The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.